WO2008000466A3 - Verwendung einer antimikrobiellen härtenden alginatmasse zur topischen behandlung von wunden und entzündungen in der human-, zahn- und veterinärmedizin sowie für kosmetische zwecke - Google Patents

Verwendung einer antimikrobiellen härtenden alginatmasse zur topischen behandlung von wunden und entzündungen in der human-, zahn- und veterinärmedizin sowie für kosmetische zwecke Download PDF

Info

Publication number
WO2008000466A3
WO2008000466A3 PCT/EP2007/005701 EP2007005701W WO2008000466A3 WO 2008000466 A3 WO2008000466 A3 WO 2008000466A3 EP 2007005701 W EP2007005701 W EP 2007005701W WO 2008000466 A3 WO2008000466 A3 WO 2008000466A3
Authority
WO
WIPO (PCT)
Prior art keywords
inflammations
dental
human
veterinary medicine
wounds
Prior art date
Application number
PCT/EP2007/005701
Other languages
English (en)
French (fr)
Other versions
WO2008000466A2 (de
Inventor
Hans H Schulz
Original Assignee
Hans H Schulz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans H Schulz filed Critical Hans H Schulz
Publication of WO2008000466A2 publication Critical patent/WO2008000466A2/de
Publication of WO2008000466A3 publication Critical patent/WO2008000466A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Verwendung eines Mehrkomponenten-Mittels, das am Anwendungsort zu einer formstabilen Alginatmasse aushärtet, die bekannten Alginat-Abformmassen ähnlich ist, jedoch einen die Absorption von wässrigen Flüssigkeiten und deren Diffusion in die und aus der gehärteten Masse erhöhenden ersten Zusatz sowie einen zweiten Zusatz in Form mindestens eines antimikrobiellen Wirkstoffs und/oder eines kosmetischen Wirkstoffs enthält, als Mittel zur Behandlung von äußeren Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin und zur lokalen Infektions- und Entzündungsprävention sowie für kosmetische Zwecke.
PCT/EP2007/005701 2006-06-27 2007-06-27 Verwendung einer antimikrobiellen härtenden alginatmasse zur topischen behandlung von wunden und entzündungen in der human-, zahn- und veterinärmedizin sowie für kosmetische zwecke WO2008000466A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006029500A DE102006029500A1 (de) 2006-06-27 2006-06-27 Verwendung einer antimikrobiellen härtenden Alginatmasse zur topischen Behandlung von Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin
DE102006029500.5 2006-06-27

Publications (2)

Publication Number Publication Date
WO2008000466A2 WO2008000466A2 (de) 2008-01-03
WO2008000466A3 true WO2008000466A3 (de) 2008-05-22

Family

ID=38776805

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/005701 WO2008000466A2 (de) 2006-06-27 2007-06-27 Verwendung einer antimikrobiellen härtenden alginatmasse zur topischen behandlung von wunden und entzündungen in der human-, zahn- und veterinärmedizin sowie für kosmetische zwecke

Country Status (2)

Country Link
DE (1) DE102006029500A1 (de)
WO (1) WO2008000466A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008022086A1 (de) 2008-05-05 2009-11-12 Schulz, Hans H. Zweikomponenten-Alginat
WO2010117266A1 (en) * 2009-04-06 2010-10-14 Broockeville Corporation N.V. In situ gelling alginate systems
GB2490516A (en) * 2011-05-03 2012-11-07 Systagenix Wound Man Ip Co Bv Polysaccharide mould for wound treatment
US11834496B2 (en) * 2020-04-02 2023-12-05 Eos Biomaterials Inc. Composition of a drug carrier, pharmaceutical composition thereof, preparation method and use method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (de) * 1964-10-14 1966-01-31
EP0380253A2 (de) * 1989-01-24 1990-08-01 Minnesota Mining And Manufacturing Company Wundverband aus Alginathydrogelschaum
WO1994000134A1 (en) * 1992-06-30 1994-01-06 Howmedica Inc. Preventing tissue adhesion using in situ modification of alginate
WO2001045679A2 (de) * 1999-12-22 2001-06-28 Schulz Hans Herrmann Verwendung von chemotherapeutika zur topischen behandlung
WO2002045661A1 (de) * 2000-12-08 2002-06-13 3M Espe Ag Verwendung von abformmassen zur herstellung von behandlungsvorrichtungen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (de) * 1964-10-14 1966-01-31
EP0380253A2 (de) * 1989-01-24 1990-08-01 Minnesota Mining And Manufacturing Company Wundverband aus Alginathydrogelschaum
WO1994000134A1 (en) * 1992-06-30 1994-01-06 Howmedica Inc. Preventing tissue adhesion using in situ modification of alginate
WO2001045679A2 (de) * 1999-12-22 2001-06-28 Schulz Hans Herrmann Verwendung von chemotherapeutika zur topischen behandlung
WO2002045661A1 (de) * 2000-12-08 2002-06-13 3M Espe Ag Verwendung von abformmassen zur herstellung von behandlungsvorrichtungen

Also Published As

Publication number Publication date
DE102006029500A1 (de) 2008-01-03
WO2008000466A2 (de) 2008-01-03

Similar Documents

Publication Publication Date Title
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
EE05311B1 (et) Meetod mineraalse t„iteaine t””tlemiseks poldialklsiloksaani ja rasvhappega, saades hdrofoobsed t„iteained, ja nende kasutamine polmeerides ''hingavate'' kilede jaoks
BRPI0906181A2 (pt) "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer"
BRPI0621170B8 (pt) pó hesmostático, bandagem hesmostática para feridas e método de manufatura de um pó hesmostático
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
BR0306501A (pt) Método para uso e produção de um tampão com medicamento
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
WO2008000466A3 (de) Verwendung einer antimikrobiellen härtenden alginatmasse zur topischen behandlung von wunden und entzündungen in der human-, zahn- und veterinärmedizin sowie für kosmetische zwecke
TW200635616A (en) Organic compounds
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
WO2010018559A3 (en) Formulations for a two-phase management of wound healing and dressings incorporating such formulations.
BRPI0611526A2 (pt) composição tópica contendo gelatina
EA200800537A1 (ru) Маррубиин и композиция для уменьшения храпа, упаковка и методика
DE602006005637D1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
ATE397935T1 (de) Pharmazeutische zubereitung zur applikation auf die haut mit einem gehalt an drospirenon
EP1603595A4 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
WO2007138233A3 (fr) Utilisation du zatosetron pour le traitement de la rosacee
ATE404209T1 (de) Wundheilende pharmazeutische zusammensetzung enthaltend sucralfat, glycin, aluminium acetat und vitamine
WO2007080511A3 (en) Dermocosmetic composition comprising at least one antimycotic substance combined with a reepithelizing substance
WO2004087091A3 (fr) Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisation et procede de traitement dermatologique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07785862

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07785862

Country of ref document: EP

Kind code of ref document: A2